"Parker Adventist Hospital offers world class doctors, compassionate care, and a broad array of medical specialties close to home."

During the past decade, Parker Adventist Hospital conducted 131 clinical trials. In the 10-year time frame, 131 clinical trials started and 94 clinical trials were completed, i.e. on average, 71.8% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 54 clinical trials were completed. i.e. 138.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parker Adventist Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 114 trials, followed by "SWOG Cancer Research Network" with 42 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parker Adventist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Parker Adventist Hospital" are "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Parker Adventist Hospital" in a lesser frequency.

Most popular intervention types in "Parker Adventist Hospital" are "Drug" (192 trials), "Other" (144 trials), "Biological" (109 trials), "Procedure" (58 trials) and "Radiation" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (70 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (37 trials), "Computed Tomography" (32 trials) and "Paclitaxel" (31 trials). Other intervention names were less common.

The vast majority of trials in "Parker Adventist Hospital" are 196 trials for "All" genders, 35 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Parker Adventist Hospital". undefined are not yet recruiting, 68 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Parker Adventist Hospital, 3 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Parker Adventist Hospital, 4 "Phase 1" clinical trials were conducted, 118 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".